TISSUE & FFPE COHORT COLLECTIONS
Liver cancer (HCC) tissue microarrays & FFPE blocks
Compare focused and multi-tumor arrays containing hepatocellular carcinoma, including selected RNAscope-prequalified collections. Histopathology, assay qualification and associated records vary by array.
THE ARRAYS
Liver cancer (HCC) arrays (11)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
IllustrationHCC (primary & mets) TMA with follow up & PD-L1 (22C3) data (TA4431)
- Approx. cores
- 90
- Approx. donors
- 90
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
HCC RNAscope pre-qualified TMA with histopath data (TA4430)
- Approx. cores
- 46
- Approx. donors
- 46
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
HCC TMA (TA4361)
- Approx. cores
- 90
- Approx. donors
- 30
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
HCC TMA with follow up, survival data & PD-L1 (22C3) data (TA4432)
- Approx. cores
- 72
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 5 of a set of 6 TMAs: HCC, Small bowel, UUT/TCC, Cutaneous SCC, Mesothelioma, Bladder (UC) with histopath data. 1x1mm core each from tumor & invasive edge (TA3128)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
IO Multi tumor array 5 of a set of 6 TMAs: HCC, Small bowel, UUT/TCC, Cutaneous SCC, Mesothelioma, Bladder (UC) with histopath data. 1x1mm core each from tumor & invasive edge (TA4442)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array 3 of a set of 4 TMAs : Small Cell Lung Cancer (SCLC), HD, HCC, RCC, GBM, GEJ, Cervical with histopath data (TA2997)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from Pancreatic, Melanoma, Breast, HCC & CRC. TMA2 of a set of 2 TMAs, histopath data (TA4313)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising HCC RCC GBM & Pancreatic ADC, histopath data (TA2565)
- Approx. cores
- 92
- Approx. donors
- 46
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, CRC, PDAC, Gastric ADC, HCC, GEJ (TA3105)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, HCC, small bowel, UUT, CSCC, mesothelioma, bladder (UC) (TA3106)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Liver cancer (HCC) FFPE blocks for your study
HCC cohorts with histopathology, follow-up, survival or PD-L1 (22C3) data.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Liver cancer (HCC) FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #105
HCC (primary & mets) with follow up & PD-L1 (22C3) data
Cohort #106
HCC with follow up, survival data & PD-L1 (22C3) data
Cohort #107
HCC with histopath data
Hepatocellular carcinoma · Patient profile
Adjuvant cohorts
Hepatocellular carcinoma · Patient profile
Neoadjuvant cohorts
Hepatocellular carcinoma · Patient profile
Stage III/IV or metastatic disease
Hepatocellular carcinoma · Patient profile
GPC3-positive hepatocellular carcinoma
SELECTING YOUR ARRAY
Selecting liver cancer (hcc) tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.